Robert J. Brilon - 23 Feb 2026 Form 4 Insider Report for Iveda Solutions, Inc. (IVDA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
25 Feb 2026, 16:30:27 UTC
Prior SEC filing
31 Dec 2025
Next SEC filing
04 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Robert J Brilon

Key filing fact

Robert J. Brilon filed Form 4 for Iveda Solutions, Inc. (IVDA) on 25 Feb 2026.

Key facts

  • This page summarizes Robert J. Brilon's Form 4 filing for Iveda Solutions, Inc. (IVDA).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 25 Feb 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 31 Dec 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001221830 Primary reporting owner

BRILON ROBERT J

Relationship
Chief Financial Officer
Address
1744 S. VAL VISTA DRIVE,, STE. 213, MESA
Signature
/s/ Robert J Brilon
Signature date
25 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IVDA transaction Derivative

Options (Right to Buy)

Disposed to Issuer

Transaction value
$0
Shares
+125,000
Change %
+454%
Price
$0.000000
Shares after
152,503
Date
29 Dec 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
125,000
Exercise price
$0.8200
IVDA transaction Derivative

Options (Right to Buy)

Award

Transaction value
$0
Shares
+125,000
Change %
+454%
Price
$0.000000
Shares after
152,503
Date
23 Feb 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
125,000
Exercise price
$0.2900
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On February 23, 2026, the Issuer's Board of Directors approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced to an exercise price of $0.29 per share. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .